Jump Financial, LLC Citius Pharmaceuticals, Inc. Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.48 - $1.02 $13,646 - $28,999	-28,431 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$0.58 - $1.03 $16,489 - $29,283	28,431 New	28,431 $16,000
Q1 2023 Oct 21, 2024	BUY	$0.78 - $1.42 $29,415 - $53,551	37,712 Added 132.64%	66,143 $77,000
Q1 2023 May 03, 2023	BUY	$0.78 - $1.42 $13,175 - $23,986	16,892 Added 34.3%	66,143 $77,000
Q4 2022 Feb 13, 2023	BUY	$0.79 - $1.28 $38,908 - $63,041	49,251 New	49,251 $38,000
Q3 2021 Nov 12, 2021	SELL	$1.74 - $2.6 $32,771 - $48,968	-18,834 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$1.51 - $4.23 $28,439 - $79,667	18,834 New	18,834 $66,000

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $378M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.